Oova Review: Fertility Changes on These Medications
Oova measures hormone levels from urine at home, quantifying luteinising hormone and progesterone metabolite rather than giving a simple positive or negative, which allows more precise ovulation tracking than standard predictor kits. It is a fertility tracking product. It appears on this site for a specific and consequential reason: GLP-1 treatment changes fertility, in directions people do not expect, and the consequences of not knowing that are significant.
Verified August 25, 2026. Oova provides hormone tracking, not medical diagnosis. Fertility concerns warrant assessment by a clinician. For weight-loss medication see our GLP-1 provider rankings.
Affiliate disclosure: Rx Saver Hub earns a commission if you sign up through links on this page. It does not change what we write — see our disclosure policy.
Verdict: A genuinely more informative approach than the standard test strip, in a situation this site's readers face more often than they realise. Quantifying hormone levels rather than reporting a threshold crossing gives a fuller picture of a cycle, which matters particularly for irregular cycles where a simple positive or negative frequently misses the window. For anyone with PCOS — common in this population, and often improved by weight loss — that granularity is more useful than a binary result. The essential context is below and it applies whether or not you buy anything.
What Oova Costs
At-home hormone testing prices by test quantity and subscription.
| Plan | What you get | Listed | Real cost |
|---|---|---|---|
| Test kits | Quantified hormone measurement | By quantity | More informative than strips |
| Standard ovulation strips | Threshold positive or negative | Much cheaper | Misses irregular cycles |
| Clinical fertility assessment | Bloodwork and imaging | Via a clinician | Diagnostic rather than tracking |
| Contraception review | With a clinician | Consultation | The urgent one for many readers |
GLP-1 treatment changes fertility and contraception in ways people are not told
Three things. Weight loss frequently restores regular ovulation in women who had irregular cycles, particularly with PCOS — so fertility can improve substantially and unexpectedly. Tirzepatide has a documented interaction with oral contraceptives: delayed gastric emptying reduces absorption, and the labelling advises switching to a non-oral method or adding a barrier method for four weeks after starting and after each dose increase. And these medications are not recommended in pregnancy, with guidance to stop well before conception — for semaglutide at least two months, given its long half-life. Together those explain why unplanned pregnancies happen on these medications.
If you are of childbearing age on a GLP-1 and not intending to conceive, the contraception review matters more than any tracking product.
Why fertility changes matter here specifically
Excess weight is associated with irregular ovulation through hormonal disruption, and polycystic ovary syndrome — a leading cause of ovulatory infertility — is strongly associated with insulin resistance and excess weight.
Meaningful weight loss frequently improves both. Cycles become more regular, ovulation resumes, and fertility improves in women who may have concluded years earlier that conception was unlikely and adjusted their contraception accordingly.
That is genuinely good news for anyone trying to conceive and a significant risk for anyone not. The same physiological improvement produces both outcomes depending on intent.
Layer the tirzepatide contraceptive absorption issue on top and you have two independent mechanisms pushing in the same direction. It is worth a conversation with a clinician rather than an assumption.
If you are trying to conceive
Timing is the first question and it is a medication question rather than a tracking one. GLP-1 medications are not recommended in pregnancy and the guidance is to stop well in advance of conception — for semaglutide at least two months. Discuss the timeline with your prescriber before you start trying, not after.
Folate before conception is standard advice for a reason: adequate folate substantially reduces neural tube defect risk and the critical window is often before a pregnancy is confirmed.
If you have lost significant weight on sharply reduced intake, discuss nutritional status. Iron, B12 and vitamin D are all plausible shortfalls after a sustained drop in food intake, and they matter more going into pregnancy.
And male factors contribute to roughly half of infertility cases while receiving a fraction of the attention. Sperm parameters respond to weight, sleep and lifestyle over a roughly three-month cycle, and TRT suppresses fertility substantially — worth raising before starting it, not after.
What quantified tracking adds over standard strips
Standard ovulation predictor kits report whether luteinising hormone has crossed a threshold, which works reasonably in regular cycles and poorly in irregular ones — where LH can surge without ovulation, or fluctuate around the threshold producing confusing results.
Measuring actual levels rather than a threshold crossing gives a curve rather than a binary, which is more interpretable when cycles are irregular. Adding a progesterone metabolite measurement helps confirm ovulation actually occurred, which an LH test alone cannot do.
That is a real methodological improvement for the population most likely to need it. It is tracking rather than diagnosis, and persistent difficulty conceiving warrants clinical assessment rather than more data collection.
Pros and Cons
Strengths
- Quantified hormone levels rather than a threshold positive or negative
- Progesterone metabolite measurement helps confirm ovulation occurred
- More useful than standard strips for irregular cycles and PCOS
- At-home collection without clinic visits
Drawbacks
- More expensive than standard ovulation predictor kits
- Tracking rather than diagnosis — persistent difficulty needs clinical assessment
- Does not address the medication timing question, which comes first
- More data can prolong self-management when assessment is warranted
Who Should Pick It — and Who Shouldn't
Good fit
Someone with irregular cycles or PCOS trying to conceive, who has already settled the GLP-1 timing question with their prescriber.
Look elsewhere
Anyone on a GLP-1 not intending to conceive — the contraception review is the urgent conversation, not tracking. And anyone who has been trying without success long enough to warrant clinical assessment.
Frequently Asked Questions
Does a GLP-1 affect fertility?
It can improve it substantially. Weight loss frequently restores regular ovulation, particularly in women with PCOS, so fertility can return unexpectedly in someone who had concluded conception was unlikely. That is good news if you are trying and a significant risk if you are not.
Does tirzepatide affect birth control?
Yes. Delayed gastric emptying reduces oral contraceptive absorption, and the labelling advises switching to a non-oral method or adding a barrier method for four weeks after starting treatment and after each dose increase. Speak to your prescriber or a pharmacist specifically about this.
Can I take a GLP-1 while trying to conceive?
These medications are not recommended in pregnancy and the guidance is to stop well before conception — for semaglutide at least two months, reflecting its long half-life. Discuss the timeline with your prescriber before you start trying.
Why is quantified hormone testing better than strips?
Standard kits report whether LH crossed a threshold, which works in regular cycles and poorly in irregular ones where LH can fluctuate or surge without ovulation. Measuring actual levels gives a curve rather than a binary, and a progesterone metabolite measurement helps confirm ovulation actually happened.
Considering Oova?
If you are of childbearing age and on a GLP-1, review contraception with a clinician — fertility improves and tirzepatide reduces oral contraceptive absorption. That comes before any tracking decision.
More Reviews Like This
Other brands we have reviewed in the same category.
Product model read from oova.life on August 25, 2026 and subject to change. Contraceptive and pregnancy guidance reflects published prescribing information for GLP-1 receptor agonists. This page is informational and not medical advice. Rx Saver Hub earns a commission on purchases made through links on this page.